Skip to content
DataLookout
Menu

SUMANCT07053709

Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD)

StatusActive, Not Recruiting
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 7 words Show 5 more changesShow less
    • Trial status changed: Not Yet Recruiting → Active, Not Recruiting
    • Primary completion date changed from estimate of Nov 1, 2026 to Jun 1, 2026
    • Study completion moved earlier from Nov 1, 2027 to Nov 1, 2026
    • Study sites: 0 to 1
    • Start date changed from estimate of Nov 1, 2026 to May 1, 2025
  2. Notable Start date: Nov 1, 2025 to Nov 1, 2026v3
  3. Notable Primary completion date: May 1, 2026 to Nov 1, 2026
    • Start date: Jul 1, 2025 to Nov 1, 2025
    • Study completion date: May 1, 2027 to Nov 1, 2027
    v2
  4. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Search for hyperuricemia in every patient with MAFLD
Timeframe: At diagnosis and follow up after 6 month

Sites

1 site in 1 country

  • Assiut UniversityAsyut, Egypt